Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aldeyra Therapeutics

2.66
+0.21008.57%
Post-market: 2.61-0.0500-1.88%19:43 EDT
Volume:662.05K
Turnover:1.72M
Market Cap:159.32M
PE:-2.75
High:2.67
Open:2.51
Low:2.47
Close:2.45
Loading ...

Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025

Reuters
·
29 May

CORRECTED-US FDA approves Alcon's new dry-eye drug (May 28)

Reuters
·
29 May

Aldeyra Therapeutics: Strong Financial Position and Positive Trial Outcomes Drive Buy Rating

TIPRANKS
·
21 May

Aldeyra Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
19 May

Aldeyra Therapeutics: Buy Rating Backed by Promising Phase 3 Results and Strategic Partnerships

TIPRANKS
·
19 May

BRIEF-Aldeyra Therapeutics Inc Says New Drug Application Resubmission Is Anticipated Mid‑2025

Reuters
·
06 May

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans Nda Resubmission

THOMSON REUTERS
·
06 May

Aldeyra Therapeutics Inc - New Drug Application Resubmission Is Anticipated Mid‑2025

THOMSON REUTERS
·
06 May

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission

Business Wire
·
06 May

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap

Business Wire
·
06 May

Aldeyra Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
29 Apr

Aldeyra Therapeutics Appoints Chip Clark to Board

TIPRANKS
·
18 Apr

Aldeyra options imply 12.1% move in share price post-earnings

TIPRANKS
·
15 Apr

Aldeyra options imply 17.5% move in share price post-earnings

TIPRANKS
·
08 Apr

Aldeyra Therapeutics Is Maintained at Buy by BTIG

Dow Jones
·
07 Apr

Aldeyra price target lowered to $9 from $11 at BTIG

TIPRANKS
·
07 Apr

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX): When Will It Breakeven?

Simply Wall St.
·
07 Apr

Aldeyra Therapeutics Inc : Jonestrading Cuts Target Price to $6 From $10

THOMSON REUTERS
·
04 Apr

Aldeyra Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Apr

Aldeyra Therapeutics Receives FDA Complete Response Letter

TIPRANKS
·
04 Apr